BioWin supports research and innovation in the fields of biopharma, medtech and digital health.
The cluster has defined its strategy and its 2020-2023 objectives. These largely stem from the discussions carried out in the various Task Forces initiated in 2018. For the next three years, BioWin intends to address two strategic projects.
Within the next decade, Wallonia has the potential to become one of the largest global hubs for biomanufacturing: the industrial production of vaccines and biologics. BioWin will undertake a range of activities to support the development of this sector.
BioWin will support Wallonia by assisting in and promoting the decompartmentalization of the hospital and corporate worlds and structuring hospital networks.
The health crisis caused by COVID-19 will require a reorganization of our health care systems and innovation within hospitals. It has also helped to partially bridge the gap between two worlds that are too compartmentalized: those of hospital and business.
During this emergency, many technological, digital and organizational innovations have emerged in record time, thanks to the collaboration between players from the hospital, entrepreneurial and academic worlds.
Over the next few years, we need to support and accelerate this movement. In particular, digital technologies and artificial intelligence will be necessary to support healthcare teams.
The cluster will contribute to this large-scale project by:
View available jobs within one of these exciting areas